Guangdong Biolight Meditech Co Ltd (SHE:300246) — Market Cap & Net Worth
Market Cap & Net Worth: Guangdong Biolight Meditech Co Ltd (300246)
Guangdong Biolight Meditech Co Ltd (SHE:300246) has a market capitalization of $685.28 Million (CN¥4.68 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #10953 globally and #3239 in its home market, demonstrating a 8.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangdong Biolight Meditech Co Ltd's stock price CN¥17.70 by its total outstanding shares 264581233 (264.58 Million). Analyse Guangdong Biolight Meditech Co Ltd cash flow conversion to see how efficiently the company converts income to cash.
Guangdong Biolight Meditech Co Ltd Market Cap History: 2015 to 2026
Guangdong Biolight Meditech Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $962.23 Million to $685.28 Million (0.35% CAGR).
Guangdong Biolight Meditech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangdong Biolight Meditech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.24x
Guangdong Biolight Meditech Co Ltd's market cap is 0.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $962.23 Million | $380.51 Million | $23.92 Million | 2.53x | 40.23x |
| 2016 | $778.61 Million | $594.31 Million | $67.14 Million | 1.31x | 11.60x |
| 2017 | $483.32 Million | $711.47 Million | $57.55 Million | 0.68x | 8.40x |
| 2018 | $258.56 Million | $813.39 Million | $64.19 Million | 0.32x | 4.03x |
| 2019 | $367.89 Million | $825.96 Million | $64.71 Million | 0.45x | 5.68x |
| 2020 | $626.66 Million | $1.40 Billion | $346.15 Million | 0.45x | 1.81x |
| 2021 | $543.82 Million | $1.09 Billion | $63.79 Million | 0.50x | 8.52x |
| 2022 | $413.91 Million | $1.18 Billion | $22.13 Million | 0.35x | 18.70x |
| 2023 | $398.78 Million | $1.19 Billion | -$65.19 Million | 0.33x | N/A |
| 2024 | $255.14 Million | $1.06 Billion | -$71.44 Million | 0.24x | N/A |
Competitor Companies of 300246 by Market Capitalization
Companies near Guangdong Biolight Meditech Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Guangdong Biolight Meditech Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Guangdong Biolight Meditech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Guangdong Biolight Meditech Co Ltd's market cap moved from $962.23 Million to $ 685.28 Million, with a yearly change of 0.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥685.28 Million | +118.52% |
| 2025 | CN¥313.60 Million | +22.91% |
| 2024 | CN¥255.14 Million | -36.02% |
| 2023 | CN¥398.78 Million | -3.66% |
| 2022 | CN¥413.91 Million | -23.89% |
| 2021 | CN¥543.82 Million | -13.22% |
| 2020 | CN¥626.66 Million | +70.34% |
| 2019 | CN¥367.89 Million | +42.29% |
| 2018 | CN¥258.56 Million | -46.50% |
| 2017 | CN¥483.32 Million | -37.92% |
| 2016 | CN¥778.61 Million | -19.08% |
| 2015 | CN¥962.23 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Guangdong Biolight Meditech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $685.28 Million USD |
| MoneyControl | $685.28 Million USD |
| MarketWatch | $685.28 Million USD |
| marketcap.company | $685.28 Million USD |
| Reuters | $685.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more